• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply.关于“莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究”的外部有效性的担忧——作者回复
Lancet Reg Health Eur. 2022 Mar 22;15:100344. doi: 10.1016/j.lanepe.2022.100344. eCollection 2022 Apr.
2
Correction to "Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors' reply".对《莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究》的关注——作者回复的勘误
Lancet Reg Health Eur. 2022 Jul 22;19:100449. doi: 10.1016/j.lanepe.2022.100449. eCollection 2022 Aug.
3
Concerns about the external validity of the study 'Prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'.对研究“莱姆病疏螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究”的外部有效性的担忧。
Lancet Reg Health Eur. 2022 Mar 22;15:100340. doi: 10.1016/j.lanepe.2022.100340. eCollection 2022 Apr.
4
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).治疗莱姆病后持续性症状的患病率及其决定因素：一项观察性、前瞻性队列研究（LymeProspect）的研究方案。
BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8.
5
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究。
Lancet Reg Health Eur. 2021 May 27;6:100142. doi: 10.1016/j.lanepe.2021.100142. eCollection 2021 Jul.
6
Classical Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study.经典血清学无助于诊断归因于莱姆病的持续症状：一项回顾性队列研究。
Life (Basel). 2023 May 6;13(5):1134. doi: 10.3390/life13051134.
7
Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.治疗莱姆病后持续性症状的决定因素：一项前瞻性观察队列研究。
EBioMedicine. 2023 Dec;98:104825. doi: 10.1016/j.ebiom.2023.104825. Epub 2023 Nov 27.
8
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.HUMTICK研究：关于比利时莱姆病治疗后综合征以及莱姆病螺旋体病的疾病和成本负担的前瞻性队列研究方案。
Arch Public Health. 2017 Aug 7;75:42. doi: 10.1186/s13690-017-0202-z. eCollection 2017.
9
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].对《莱姆病螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究》[《柳叶刀区域健康 - 欧洲》6（2021）100142]的更正
Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr.
10
Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis.莱姆病和其他蜱传疾病。法国科学学会指南（二）。生物学诊断、治疗、有记录或疑似莱姆病后持续存在的症状。
Med Mal Infect. 2019 Aug;49(5):335-346. doi: 10.1016/j.medmal.2019.05.001. Epub 2019 May 31.

引用本文的文献

1
Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires.在莱姆病专业中心就诊患者的评估和 1 年随访：一项前瞻性队列研究，采用了经过验证的问卷。
Eur J Clin Microbiol Infect Dis. 2024 May;43(5):937-946. doi: 10.1007/s10096-024-04770-6. Epub 2024 Mar 16.

本文引用的文献

1
Concerns about the external validity of the study 'Prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'.对研究“莱姆病疏螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究”的外部有效性的担忧。
Lancet Reg Health Eur. 2022 Mar 22;15:100340. doi: 10.1016/j.lanepe.2022.100340. eCollection 2022 Apr.
2
Post-treatment Lyme borreliosis in context: Advancing the science and patient care.治疗后莱姆病螺旋体病的相关情况：推动科学发展与患者护理。
Lancet Reg Health Eur. 2021 Jun 27;6:100153. doi: 10.1016/j.lanepe.2021.100153. eCollection 2021 Jul.
3
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究。
Lancet Reg Health Eur. 2021 May 27;6:100142. doi: 10.1016/j.lanepe.2021.100142. eCollection 2021 Jul.
4
Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months.前瞻性评估游走性红斑莱姆病患者与基线、6 个月和 12 个月时匹配对照者的症状频率和严重程度。
Clin Infect Dis. 2020 Dec 15;71(12):3118-3124. doi: 10.1093/cid/ciz1215.
5
Comparison of Clinical Course and Treatment Outcome for Patients With Early Disseminated or Early Localized Lyme Borreliosis.早期播散型或早期局限型莱姆病患者的临床病程与治疗结果比较
JAMA Dermatol. 2018 Sep 1;154(9):1050-1056. doi: 10.1001/jamadermatol.2018.2306.
6
Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.早期莱姆病患者症状随时间的标准化测量。
Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.
7
Physician reported incidence of early and late Lyme borreliosis.医生报告的早期和晚期莱姆病疏螺旋体病发病率。
Parasit Vectors. 2015 Mar 15;8:161. doi: 10.1186/s13071-015-0777-6.
8
Subjective symptoms after treatment of early Lyme disease.治疗早期莱姆病后的主观症状。
Am J Med. 2010 Jan;123(1):79-86. doi: 10.1016/j.amjmed.2009.05.011.
9
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.莱姆病、人粒细胞无形体病和巴贝斯虫病的临床评估、治疗及预防：美国传染病学会临床实践指南
Clin Infect Dis. 2006 Nov 1;43(9):1089-134. doi: 10.1086/508667. Epub 2006 Oct 2.

Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply.

作者信息

van den Wijngaard Cees C, Ursinus Jeanine, Vrijmoeth Hedwig D, Knoop Hans, Wong Albert, Joosten Leo A B, Hovius Joppe W, Kullberg Bart Jan

机构信息

National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, P.O. Box 1, Bilthoven, 3720 BA, the Netherlands.

Department of Internal Medicine, Division of Infectious Diseases and Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, P.O. Box 22660, Amsterdam, 1100 DD, the Netherlands.

出版信息

Lancet Reg Health Eur. 2022 Mar 22;15:100344. doi: 10.1016/j.lanepe.2022.100344. eCollection 2022 Apr.

DOI:10.1016/j.lanepe.2022.100344
PMID:35342893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8943426/
Abstract
摘要